Revolution Medicines (RVMD) Earnings Date & Reports

A.I. Advisor

published Earnings

RVMD is expected to report earnings to rise 10.04% to -89 cents per share on November 04

Revolution Medicines RVMD Stock Earnings Reports

Q3'24

Est.

$-0.89

Q2'24

Missed

by $0.04

Q1'24

Beat

by $0.05

Q4'23

Missed

by $0.29

Q3'23

Beat

by $0.02

The last earnings report on August 07 showed earnings per share of -81 cents, missing the estimate of -77 cents. With 534.93K shares outstanding, the current market capitalization sits at 7.38B.

View a ticker or compare two or three

Compare

RVMD

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For RVMD
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for RVMD (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

an oncology company, which focused on developing novel targeted therapies and engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment.

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

700 Saginaw Drive

Phone

+1 650 481-6801

Employees

378

Web

https://www.revmed.com